At Recursion, we combine experimental biology, automation, and artificial intelligence to quickly and efficiently identify treatments for human diseases. The Director of Regulatory Affairs is responsible for setting the regulatory strategy and the management of regulatory aspects of the company’s development projects.
THE PROBLEMS YOU’LL SOLVE
We are looking to get multiple programs—in a variety of therapeutic areas—into the clinic in the next few years; this kind of ambition requires innovation, focus, and a true ability to think about development in a new light. The position reports to the SVP of Strategic Development, and will oversee both the strategic and tactical domains of our regulatory operations. In addition, you will perform due diligence activities on in-licensing opportunities and provide regulatory subject matter expertise as we out-license programs. If you are looking for autonomy and the opportunity to build a regulatory affairs function from the ground up, let’s talk.
In this role you will:
THE EXPERIENCE YOU’LL NEED
THE PERKS YOU’LL ENJOY
WHAT WE DO
We start with various human cell types in our automated laboratory, where we perturb biology 100,000 different ways each week (e.g. model a disease of interest, add a chemical compound, or some combination of those). We image the resulting cells using high throughput microscopy, resulting in about 2 million new images (or greater than 20 terabytes of data) each week. These data are analyzed using computer vision and machine learning methods that help us measure how cell morphology changes in subtle ways in each biological context. We can answer direct questions (e.g. are there compounds that rescues a disease-specific set of morphological changes), and over time as our dataset has increased, we can ask more complex questions across biology.
From the outset, our approach is agnostic to preconceived notions and dogma in biology, enabling Recursion to operate in novel target space. In order to move the discovery and development process more quickly and with higher confidence, we are expanding this platform to enable us to use our image-based dataset to make predictions about biological pathways, mechanism and how each potential therapeutic will perform in later IND-enabling studies, including ADME, Tox, etc. We are also evaluating what additional high-dimensional biological datasets could extend our predictive capacity with the aim to extend our predictive capabilities and further accelerate drug discovery and development.
Recursion is an equal opportunity employer and complies with all applicable federal, state, and local fair employment practices laws. Recursion strictly prohibits and does not tolerate discrimination against applicants because of race, color, religion, creed, national origin or ancestry, ethnicity, sex, pregnancy, gender (including gender nonconformity and status as a transgender individual), age, physical or mental disability, citizenship, past, current, or prospective service in the uniformed services, or any other characteristic protected under applicable federal, state, or local law.